Key Takeaways
There are several reasons to be constructive about emerging markets (EMs) heading into 2022.
- Equity valuations appear to have priced in much caution and indicate attractive long-term value.
- China’s market valuations appear to be near a floor and should be well-supported from here following significant negative news over 2021. While near-term headwinds from regulatory uncertainty and its “zero-COVID-19” stance could extend into 2022, policymakers stand ready to stabilize economic growth if needed.
- Across EMs, positive structural forces remain apparent and are likely to foster fresh investment opportunities. Digitalization and decarbonization are key themes to watch.
- Fiscal and current accounts are also in better shape than before, potentially ruling out a repeat of the severe market stresses that hit EMs in previous down cycles.
Measured Optimism
2021 has been a challenging year for EMs. Mixed vaccination progress across countries contributed to false starts in exiting the pandemic. Economic reopenings in EMs and reopening trades in their stock markets subsequently lagged those in developed markets (DMs). China was a key concern—tighter fiscal and monetary policies, the “Common Prosperity” campaign driving regulatory changes across industries and a zero-COVID-19 approach combined to cool investor sentiment. Worries over US inflation and the direction of US monetary policy also came to the fore. Key EMs such as Brazil, Mexico, Russia and South Korea moved ahead of DMs in raising interest rates to curb price pressures.
Yet, there are several reasons to be constructive about EMs heading into 2022. For a start, equity valuations appear to have priced in much caution and indicate attractive long-term value. The fixed income perspective is also encouraging—real yields in EMs exceed those in DMs. In this regard, we are noticing shared optimism on EMs with our fixed income colleagues.
Fiscal and current accounts across EMs are also in better shape than before. Institutional reforms in major EMs over the past few decades have strengthened their economic discipline and resilience against crises. Strong commodity prices recently have been an additional windfall for resource exporters. Sturdier EM finances potentially rule out a repeat of the severe market stresses that hit EMs in previous down cycles.
Diverse EM Drivers
China’s market valuations appear to be near a floor and should be well-supported from here following significant negative news over 2021. Granted, some near-term headwinds could extend into 2022. We expect China to maintain its zero-COVID-19 stance well into the year to safeguard the success of the Winter Olympics and the Chinese Communist Party’s 20th National Congress. International travel and other mobility restrictions will limit economic activity. Regulatory uncertainty could also continue. We believe that the recent regulatory changes are partly a function of China’s political cycle, which is likely to culminate in the 20th National Congress. As the political dust settles, regulatory clarity should eventually return, as it has in past political cycles.
On a positive note, China’s authorities have shown that they still have a strong pro-growth agenda and have no intention to choke the private sector with rules. They have the policy tools to stabilize growth and are ready to use them if needed, as we saw with the recent cut in the country’s reserve requirement ratio.
In Brazil, valuations have fallen to extremely low levels, creating interesting investment opportunities. Concerns over potential fiscal laxity, rising interest rates and the likelihood of a left-wing resurgence at next year’s general elections have led to the market selloff. Even then, Brazil’s fundamentals appear healthier to us than they have since its last recession. More recently, its fiscal and current accounts have improved, with higher oil prices aiding the net oil exporter. The macroeconomic tailwind has also played out at the company level. For example, rationalization and surging cash flows helped by rising oil prices enabled state-owned oil producer Petrobras to reduce its debt significantly in recent years.
India’s economic activity has rebounded since its second COVID-19 wave. The credit cycle has shown signs of an upturn and major banks have recorded healthy loan growth. The housing cycle has also picked up as a result of better home affordability, along with a recovery in the infrastructure cycle amid the government’s infrastructure push. A robust fiscal and current account picture has accompanied India’s cyclical acceleration.
Secular Opportunities
Across EMs, positive structural forces remain apparent and are likely to foster fresh investment opportunities. Digitalization is a key theme. India’s thriving internet economy has attracted capital seeking new areas of growth, especially in light of regulatory flux in China. E-payment, food delivery and other disruptive business models have taken off, prompting even traditional businesses to embrace innovation to counter the competition. In China, industrial digitalization has gained pace as the economy eyes progress up the value chain. Globally, the continued semiconductor shortage underscores the huge demand for chips coming from technology advancements, and we expect strong earnings for some of the world’s largest semiconductor companies in markets such as Taiwan and South Korea.
Decarbonization is another trend to watch. Major EMs’ pledges to achieve carbon neutrality is likely to intensify electrification and renewable energy efforts, creating multiyear support for relevant industries. We have seen growth for South Korean electric vehicle battery makers and Chinese solar energy companies accelerate sharply, lifting them to world-leading industry positions in the process.
Resilience Amid Risks
Certain risks could change our overall EM outlook, although they are not in our base-case scenario. For instance, a sharp and sudden rise in the US federal funds rate could trigger market volatility. Conversely, a dovish US policy surprise could help EMs outperform DMs. Meanwhile, more dangerous COVID-19 variants could emerge amid the ongoing pandemic. The market swings that followed the recent discovery of the Omicron variant serve as a reminder of the uncertainties that remain, although indicators so far suggest that the variant’s symptoms could be milder than feared. We are also watching China-Taiwan relations as cross-strait tensions brew.
As the investment environment evolves, an important feature that we seek in EMs is resilience, in terms of both their economies and companies. What especially matters to us is the sustainability of company earnings, whether in the face of COVID-19, policy changes, technology disruption or other challenges. We see companies with structural growth drivers aligned with digitalization, decarbonization and other transformative trends emerging as long-term winners, which should underpin EM equities ahead.
What Are the Risks?
All investments involve risks, including possible loss of principal. The value of investments can go down as well as up, and investors may not get back the full amount invested. Stock prices fluctuate, sometimes rapidly and dramatically, due to factors affecting individual companies, particular industries or sectors, or general market conditions. Special risks are associated with investing in foreign securities, including risks associated with political and economic developments, trading practices, availability of information, limited markets and currency exchange rate fluctuations and policies; investments in emerging markets involve heightened risks related to the same factors. To the extent a strategy focuses on particular countries, regions, industries, sectors or types of investment from time to time, it may be subject to greater risks of adverse developments in such areas of focus than a strategy that invests in a wider variety of countries, regions, industries, sectors or investments. China may be subject to considerable degrees of economic, political and social instability. Investments in securities of Chinese issuers involve risks that are specific to China, including certain legal, regulatory, political and economic risks.
There is no assurance any estimate, forecast or projection will be realized.
Important Legal Information
This material is intended to be of general interest only and should not be construed as individual investment advice or a recommendation or solicitation to buy, sell or hold any security or to adopt any investment strategy. It does not constitute legal or tax advice. This material may not be reproduced, distributed or published without prior written permission from Franklin Templeton.
The views expressed are those of the investment manager and the comments, opinions and analyses are rendered as at publication date and may change without notice. The underlying assumptions and these views are subject to change based on market and other conditions and may differ from other portfolio managers or of the firm as a whole. The information provided in this material is not intended as a complete analysis of every material fact regarding any country, region or market. There is no assurance that any prediction, projection or forecast on the economy, stock market, bond market or the economic trends of the markets will be realised. The value of investments and the income from them can go down as well as up and you may not get back the full amount that you invested. Past performance is not necessarily indicative nor a guarantee of future performance. All investments involve risks, including possible loss of principal.
Any research and analysis contained in this material has been procured by Franklin Templeton for its own purposes and may be acted upon in that connection and, as such, is provided to you incidentally. Data from third party sources may have been used in the preparation of this material and Franklin Templeton (“FT”) has not independently verified, validated or audited such data. Although information has been obtained from sources that Franklin Templeton believes to be reliable, no guarantee can be given as to its accuracy and such information may be incomplete or condensed and may be subject to change at any time without notice. The mention of any individual securities should neither constitute nor be construed as a recommendation to purchase, hold or sell any securities, and the information provided regarding such individual securities (if any) is not a sufficient basis upon which to make an investment decision. FT accepts no liability whatsoever for any loss arising from use of this information and reliance upon the comments, opinions and analyses in the material is at the sole discretion of the user.
Products, services and information may not be available in all jurisdictions and are offered outside the U.S. by other FT affiliates and/or their distributors as local laws and regulation permits. Please consult your own financial professional or Franklin Templeton institutional contact for further information on availability of products and services in your jurisdiction.
Issued in the U.S. by Franklin Distributors, LLC, One Franklin Parkway, San Mateo, California 94403-1906, (800) DIAL BEN/342-5236, franklintempleton.com – Franklin Distributors, LLC, member FINRA/SIPC, is the principal distributor of Franklin Templeton U.S. registered products, which are not FDIC insured; may lose value; and are not bank guaranteed and are available only in jurisdictions where an offer or solicitation of such products is permitted under applicable laws and regulation.
CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.
